Clivatuzumab

Clivatuzumab is a humanized anti-myxinomab, which can target the MUC1 epitope highly expressed on the surface of most pancreatic cancer cells, and has a good therapeutic effect on a variety of tumor cells.

Product Specifications

CAS Number

1622075-09-5

Stability

≥ 2 years

Purity

>98% (HPLC)

Molecular Formula

——

Notes

Research use only, not for human use.

Receptor

Others

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

EV2320 1 Each

electrophoresis ps 3000v, 150ma, 150w

View Details

30673031 100 µg

MRX65 Protein Lysate (Human) with C-Ha Tag

View Details

LS007220-20ug 20 µg

TRPC1 (NM_003304) Human Over-expression Lysate

View Details

244778 450 Pack (18 Label (s) x 25 Card)

VOLTAGE MARKERS CV 3X380V C Conduit & Voltage Markers

View Details

PT_41602-01 10 µg

N-Myc Downstream Regulated 1 Human Recombinant (NDRG1 Human)

View Details

PT_41602-02 50 µg

N-Myc Downstream Regulated 1 Human Recombinant (NDRG1 Human)

View Details